Position
Renaissance Technologies in TherapeuticsMD, Inc.
Back to the book · All holders of TXMD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $27.8K$2.02 → $2.21
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 96.5K | $157.3K | — | — | — | 0.0% |
| Q1 2026 | 146.2K | $295.3K | $2.02 | $37.6K | $100.4K | 0.0% |
| Q2 2026 | 146.6K | $324K | $2.21 | $27.8K | $882 | 0.0% |